In CD40-expressing malignancies, such as chronic lymphocytic leukemia, CD40 monoclonal antibodies (mAbs) mediate direct tumor cell death via antibody-dependent cellular cytotoxicity [163,164]. The gene discussed is CD40; the disease is B-cell chronic lymphocytic leukemia.